Background：NSP8, forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase.
Alternatively, may synthesize substantially longer products than oligonucleotide primers.
To ultimately combat the emerging COVID-19 pandemic, it is desired to develop an effective and safe vaccine against this highly contagious disease caused by the SARS-CoV-2 coronavirus.
By investigating the entire proteome of SARS-CoV-2, six proteins, including the S protein and five non-structural proteins (nsp3, 3CL-pro, and nsp8-10) were predicted to be adhesins, which are crucial to the viral adhering and host invasion.
The S, nsp3, and nsp8 proteins were also predicted by Vaxign-ML to induce high protective antigenicity.
仕様
サイズ：100ug
Source：SARS-CoV-2 NSP8, His Tag (NS8-C5149) is expressed from E.coli cells. It contains AA Ala 1 - Gln 198 (Accession # YP_009725304.1).
Molecule：NSP8
Synonyms：NSP8,nsp8,Non-structural protein 8
Species：SARS-CoV-2
Tag：His Tag
Expression Systems：E.coli
Expression Rigeion：Ala 1 - Gln 198
Conjugate：Unconjugated
Accession：YP_009725304.1
Molecular Weight：23.9 kDa
Characteristics：This protein carries a polyhistidine tag at the N-terminus. The protein has a calculated MW of 23.9 kDa. The protein migrates as 22-25 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin Level：Less than 1.0 EU per ug by the LAL method.
